menu search

CI / Cigna Group: Weaker Than Peers But Still A Buy

Cigna Group: Weaker Than Peers But Still A Buy
Cigna's Health Insurance business is weaker than its peers, while Evernorth should be the future growth driver. The balance sheet and return on equity is weaker than that of peers HUM and UNH. The low valuation, coupled with solid growth prospects, should enable investors to generate low double-digit returns. Read More
Posted: Aug 27 2023, 06:28
Author Name: Seeking Alpha
Views: 1115100

CI News  

My Top 15 High Growth Dividend Stocks For November 2023

By Seeking Alpha
November 3, 2023

My Top 15 High Growth Dividend Stocks For November 2023

The SPDR S&P 500 ETF posted its third consecutive losing month in October, the first time this has happened since I started tracking this series in Se more_horizontal

Cigna (CI) Q3 Earnings and Revenues Beat Estimates

By Zacks Investment Research
November 2, 2023

Cigna (CI) Q3 Earnings and Revenues Beat Estimates

Cigna (CI) came out with quarterly earnings of $6.77 per share, beating the Zacks Consensus Estimate of $6.66 per share. This compares to earnings of more_horizontal

Cigna posts revenue beat for the third quarter

By Market Watch
November 2, 2023

Cigna posts revenue beat for the third quarter

Cigna Group Inc. CI, +0.07% topped quarterly revenue expectations Thursday while logging increased counts of pharmacy and medical customers. The compa more_horizontal

Cigna raises 2023 profit forecast on lower medical costs

By Reuters
November 2, 2023

Cigna raises 2023 profit forecast on lower medical costs

Cigna Corp raised its full-year profit forecast on Thursday, banking on strength in its pharmacy benefit unit and lower-than-expected insurance claims more_horizontal

Top 3 Blue-Chip Stocks in the Healthcare Industry

By InvestorPlace
November 1, 2023

Top 3 Blue-Chip Stocks in the Healthcare Industry

Blue-chip companies are very well established, have an excellent reputation and boast a history of providing investors with consistent returns. Blue- more_horizontal

Cigna (CI) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

By Zacks Investment Research
November 1, 2023

Cigna (CI) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Evaluate the expected performance of Cigna (CI) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line more_horizontal

Can High Benefits and Expenses Affect Cigna (CI) Q3 Earnings?

By Zacks Investment Research
October 31, 2023

Can High Benefits and Expenses Affect Cigna (CI) Q3 Earnings?

Cigna's (CI) third-quarter results are likely to reflect growth in medical customers and pharmacy revenues. more_horizontal

Here's Why Cigna (CI) is a Strong Value Stock

By Zacks Investment Research
October 24, 2023

Here's Why Cigna (CI) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre more_horizontal


Search within

Pages Search Results: